Document Detail


Systemic administration of high-molecular weight hyaluronan stimulates wound healing in genetically diabetic mice.
MedLine Citation:
PMID:  21447385     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Hyaluronic acid (HA), an essential component of the extracellular matrix, is an efficient space filler that maintains hydration, serves as a substrate for assembly of proteoglycans and is involved in wound healing. Although numerous pieces of evidence demonstrate beneficial effects in promoting wound healing in diabetes, a systemic approach has never been tested. We used an incisional wound healing model in genetically diabetic mice to test the effects of systemic injection of HA. Diabetic (n=56) and normoglycemic (n=56) mice were subjected to incision and randomized (8 groups of 7 animals each) to receive HA at different doses: 7.5, 15 and 30 mg/kg/ip or vehicle (0.9% NaCl solution) for 12 days. At the end of the experiment animals were sacrificed and skin wounds were excised for histological, biochemical and molecular analysis. Histology revealed that the most effective dose to improve wound repair and angiogenesis in diabetic mice was 30 mg/kg. Furthermore HA injection (30 mg/kg) improved the altered healing pattern in diabetic animals, increased skin remodelling proteins TGF-β and transglutaminase-II and restored the altered expression of cyclin B1/cdc2 complex. Evaluation of skin from diabetic animals injected with HA revealed also an increase in HA content, suggesting that systemic injection may be able to restore the reduced intracellular HA pool of diabetic mice. Finally HA markedly improved skin mechanical properties. These promising results, if confirmed in a clinical setting, may improve the care and management of diabetic patients.
Authors:
Mariarosaria Galeano; Francesca Polito; Alessandra Bitto; Natasha Irrera; Giuseppe M Campo; Angela Avenoso; Margherita Calò; Patrizia Lo Cascio; Letteria Minutoli; Mauro Barone; Francesco Squadrito; Domenica Altavilla
Related Documents :
17953765 - Study protocol: insulin and its role in cancer.
1895955 - Understanding "insulin resistance": both glucose resistance and insulin resistance are ...
20634295 - Uremic cardiomyopathy and insulin resistance: a critical role for akt?
9714125 - Relation between plasma tumor necrosis factor-alpha and insulin sensitivity in elderly ...
19504715 - Intensification to biphasic insulin aspart 30/70 (biasp 30, novomix 30) can improve gly...
7584995 - Measurement of glucose in diabetic subjects using noninvasive transdermal extraction.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-3-26
Journal Detail:
Title:  Biochimica et biophysica acta     Volume:  -     ISSN:  0006-3002     ISO Abbreviation:  -     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-3-30     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0217513     Medline TA:  Biochim Biophys Acta     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2010. Published by Elsevier B.V.
Affiliation:
Department of Clinical and Experimental Medicine and Pharmacology, Section of Pharmacology, School of Medicine, University of MessinaRomeItaly; Department of Surgical Sciences, Section of Plastic Surgery, School of Medicine, University of MessinaRomeItaly.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Towards a Comprehensive Characterization of the Phosphotyrosine Proteome.
Next Document:  Early reduction of circulating homocysteine levels in Goto-Kakizaki rat, a spontaneous nonobese mode...